Monthly Archives

March 2020

Retinoids and Azelaic Acid to Treat Acne and Hyperpigmentation in Skin of Color

By | SOC Manuscripts | No Comments

There are increasing data describing the use of retinoid and azelaic acid use in skin of color for the treatment of both acne and the subsequent postinflammatory hyperpigmentation. Historically, some dermatologists have been hesitant to use retinoids in skin of color because of perceived hypersensitivity in this patient population. However, recent data support the use of retinoids and azelaic acid in skin of color as both safe and beneficial.

Tretinoin, tazarotene, and adapalene (ADA), have been successfully used to treat acne. These treatments are reviewed and their effectiveness in hyperpigmentation is discussed.

  1. Tazarotene for Postinflammatory Hyperpigmentation
    In a blinded, vehicle-controlled trial, 74 acne patients from darker racial ethnic groups (Fitzpatrick skin types IV to VI) were treated with once-daily application of tazarotene 0.1% cream.  Results showed significant reductions in overall post-inflammatory hyperpigmentation and dryness, erythema, burning, and peeling were mild in both patient groups studied.
  2. Adapalene for Acne in African American Patients An analysis of 5 trials were conducted assessing adapalene gel 0.1% for the efficacy of reduces acne lesions in African American patients.  Results showed adapalene 0.1% gel significantly reduced a greater number of inflammatory lesions among African American patients with Fitzpatrick skin types IV through VI. Adapalene may have better efficacy for inflammatory lesions in African Americans than in Caucasians and is a good choice for patients with skin of color.
  3. Adapalene for Postinflammatory Hyperpigmentation
  4. Adapalene/Benzoyl Peroxide and Tolerability in Skin of Color
  5. Benzoyl Peroxide/Clindamycin Plus Retinoid
  6. Clindamycin and Retinoid for Acne in Darker-Skinned Patients
  7. Azelaic Acid

To see the results of the remaining retinoids and azelaic acid, please read the free full-text at JDDOnline.com.

The full-text review article is available for free from the Journal of Drugs in Dermatology . The article was written by Heather C. Woolery-Lloyd MD, Jonette Keri MD, and Stefan Doig MD from the Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL.

Join Dermatology Leadership Discussion of COVID-19

By | COVID-19 Resources | No Comments
SOCU Webinar

Join Dermatology Leadership Discussion of COVID-19

Skin of Color Update and JDD invite you to attend a webinar panel to provide discussion, guidance, and leadership for dermatologists and dermatology practices during the global coronavirus pandemic.

Over the course of the 2 hours, 8 different thought leaders will join the conversation, discussing questions that are on the mind of many dermatologists in the country. Click here to register.

MODERATOR
Joel L. Cohen, MD (Director, About Skin Dermatology & Associate Clinical Professor, University of California at Irvine)

AGENDA
6:00-7:00PM
Neal Bhatia, MD (Vice President-elect of the AAD & Director of Clinical Dermatology, Therapeutics Clinical Research)
Adam Friedman, MD (Professor and Interim Chair of Dermatology, GW School of Medicine & Health Sciences)
William D. Humphries (President, Ortho Dermatologics)
Mark Kaufman, MD (Associate Clinical Professor, Icahn School of Medicine at Mount Sinai)

7:00-8:00PM
Sue Ellen Cox, MD (Founder, Aesthetic Solutions)
Kavita Mariwalla, MD (Founder, Mariwalla Dermatology)
Carrie Strom (Senior Vice President, US Medical Aesthetics at Allergan)

ARCHIVED RECORDING
This webinar will be archived for on demand viewing on JDDonline.com by end of day Friday April 3rd.

STATEMENT ABOUT COVID-19, CORONAVIRUS ACTION

By | COVID-19 Resources | No Comments
Sanovaworks Cares logo

NEW YORK (Mar. 13, 2020) – A Note from Shelley Tanner, SanovaWorks CEO/President

First and foremost, in light of the rapidly evolving global COVID-19 situation, we hope that you and your family are safe and healthy. We send companywide thoughts and prayers to the individuals, families, and other groups who have been impacted by this situation, and hope that things will improve very soon.

While many things are uncertain surrounding this virus, as an organization, SanovaWorks believes in taking action early. We are dedicated to providing the best care and support we can to all our employees and business partners.

We have the extremely good fortune to be functioning already as a virtual company and because of this we hope to be able to provide support and resources to our entire network who might not have the experience we have. Please check our blog for our tips and recommendations for transitioning to and being successful in a remote work environment:https://sanovaworks.com/2020/03/11/top-immediate-needs-of-remote-employees/

In addition to this, in order to protect our teams and others, until further notice, we have issued a complete restriction on all business-related travel. While the CDC has not placed restrictions on domestic travel, they have recently posted travel warnings on their website: https://www.cdc.gov/coronavirus/2019-ncov/travelers/travel-in-the-us.html?mod=article_inline

The CDC also provide general recommendations that we should all be following to prevent the spread of this disease:https://www.cdc.gov/coronavirus/2019-ncov/about/prevention.html

We will be working diligently as teams to connect with many of you so that we can share some very interesting ways to accomplish our results in this new, virtual environment. We have many years of experience transitioning traditional programs to digital programs, and launching successful virtual programs. Because we are already positioned as a remote company that produces virtual programs, we hope that we are able to support your own initiatives and bridge the gap this global situation has caused.

And last but not least, with a shout out to Jim Collins who introduced me to the Stockdale Paradox in his book Good To Great, we all need to look squarely at the facts, but have confidence that together we will prevail, as we balance realism with optimism.

 

Together.

Shelley and the entire SanovaWorks Team

What’s New In Treatments for Hair Loss with Amy McMichael, MD at the ODAC Dermatology Conference

By | Uncategorized | No Comments

During the 2020 ODAC Dermatology, Aesthetic and Surgical Conference, Dr. Amy McMichael, Professor and Chair of Dermatology at the Wake Forest University School of Medicine, sat down with Next Steps in Derm to share important updates regarding treatments on the horizon for the most common forms of hair loss. Dr. McMichael will be presenting at Skin of Color Update 2020 with lectures including Hair & Scalp Disorders in SOC: Diagnostic Approaches and Hot Topics & Controversies in Photoprotection: Making sense of it all.

Click here to view the full Skin of Color Update agenda.

Read More…..